Pippa Newell, MD
Pippa Newell, MD
Hepatobiliary and Pancreas Surgeon, The Oregon Clinic; Medical Director, Liver Cancer Program
Verified email at providence.org - Homepage
Cited by
Cited by
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
SM Wilhelm, L Adnane, P Newell, A Villanueva, JM Llovet, M Lynch
Molecular cancer therapeutics 7 (10), 3129-3140, 2008
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma
Y Hoshida, SMB Nijman, M Kobayashi, JA Chan, JP Brunet, DY Chiang, ...
Cancer research 69 (18), 7385-7392, 2009
Pivotal role of mTOR signaling in hepatocellular carcinoma
A Villanueva, DY Chiang, P Newell, J Peix, S Thung, C Alsinet, V Tovar, ...
Gastroenterology 135 (6), 1972-1983. e11, 2008
Genomics and signaling pathways in hepatocellular carcinoma
A Villanueva, P Newell, DY Chiang, SL Friedman, JM Llovet
Seminars in liver disease 27 (01), 055-076, 2007
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
DY Chiang, A Villanueva, Y Hoshida, J Peix, P Newell, B Minguez, ...
Cancer research 68 (16), 6779-6788, 2008
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma
A Villanueva, Y Hoshida, C Battiston, V Tovar, D Sia, C Alsinet, ...
Gastroenterology 140 (5), 1501-1512. e2, 2011
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
P Newell, S Toffanin, A Villanueva, DY Chiang, B Minguez, L Cabellos, ...
Journal of hepatology 51 (4), 725-733, 2009
Experimental models of hepatocellular carcinoma
P Newell, A Villanueva, SL Friedman, K Koike, JM Llovet
Journal of hepatology 48 (5), 858-879, 2008
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib
A Lachenmayer, C Alsinet, R Savic, L Cabellos, S Toffanin, Y Hoshida, ...
Clinical cancer research 18 (18), 4997-5007, 2012
Optimizing timing of immunotherapy improves control of tumors by hypofractionated radiation therapy
KH Young, JR Baird, T Savage, B Cottam, D Friedman, S Bambina, ...
PloS one 11 (6), e0157164, 2016
Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy
MR Crittenden, B Cottam, T Savage, C Nguyen, P Newell, MJ Gough
PloS one 7 (6), e39295, 2012
VEGF signaling in cancer treatment
D Sia, C Alsinet, P Newell, A Villanueva
Current pharmaceutical design 20 (17), 2834-2842, 2014
β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation
JM Lee, J Yang, P Newell, S Singh, A Parwani, SL Friedman, ...
Cancer letters 343 (1), 90-97, 2014
A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic …
T Crocenzi, B Cottam, P Newell, RF Wolf, PD Hansen, C Hammill, ...
Journal for immunotherapy of cancer 4 (1), 1-13, 2016
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
MR Crittenden, J Baird, D Friedman, T Savage, L Uhde, A Alice, B Cottam, ...
Oncotarget 7 (48), 78653, 2016
Umbilical hernia repair in patients with signs of portal hypertension: surgical outcome and predictors of mortality
SW Cho, N Bhayani, P Newell, MA Cassera, CW Hammill, RF Wolf, ...
Archives of Surgery 147 (9), 864-869, 2012
Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database
Z Jutric, WC Johnston, HM Hoen, PH Newell, MA Cassera, CW Hammill, ...
HPB 18 (1), 79-87, 2016
Molecular targeted therapies in hepatocellular carcinoma: from pre-clinical models to clinical trials
P Newell, A Villanueva, JM Llovet
Journal of hepatology 49 (1), 1-5, 2008
Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base
WC Johnston, HM Hoen, MA Cassera, PH Newell, CW Hammill, ...
HPB 18 (1), 21-28, 2016
TGFβ inhibition prior to hypofractionated radiation enhances efficacy in preclinical models
KH Young, P Newell, B Cottam, D Friedman, T Savage, JR Baird, ...
Cancer immunology research 2 (10), 1011-1022, 2014
The system can't perform the operation now. Try again later.
Articles 1–20